About Us

Women's Cancer Initiative- Tata Memorial Hospital and Nag Foundation Invites you for the "6th edition of Year in Review: Breast Cancer Conference". This conference will be held on a virtual platform from 11th Jan - 15th Jan from 6.00pm to 8.30pm and on 16 th Jan from 9.00am to 3.00pm.

The pandemic in 2020 has slowed down research, inspite of this many clinical, translational and basic science studies were published this year. Data presented at the YIR conference, are chosen from major breast cancer meetings and noteworthy publications from peer reviewed journals, likely to make an impact on our daily clinical practice.

The popularity of the Year In Review breast cancer relies on an unbiased selection of high quality research which is presented in an interactive form and discussed in the Indian context. A wide range of topics is reviewed ranging from Translational science to Supportive care. This aims to give participants clear visibility on how they can apply this information to their immediate practice, as well as keeping in mind the potential of new research.

Another important highlight of this meeting, is that it features experts who have been consistently part of this conference for the last 5 years. These experts understand the participants needs and expectations, while they contextualize and process new information for optimizing patient care.

This virtual meeting take place over 6 days and will be broadly classified in the following sessions:
• Monday : Loco-regional therapy
• Tuesday : HR positive Breast Cancer
• Wednesday : HER2 positive Breast Cancer
• Thursday : Triple Negative Breast Cancer
• Friday : Translational science & Supportive care
• Saturday : Keynote presentations and panel discussions

Please find below the registration link for the conference. We request you to popularise this link amongst your colleagues and students.

YIR has become an important annual meeting in India for breast cancer. We have been going strong since 2016 with your support and partnership. We urge you to be part of YIR this year as well.

We look forward to your participation in 2021.

With best wishes

Organizing Chairperson:

Dr. Sudeep Gupta
Director, ACTREC
Professor of Medical Oncology
Tata Memorial Centre

Dr. Shona Nag
Director of Oncology
Sahyadri Hospital

Scientific Program 2020

Scientific Program 2019

Scientific Program 2018

Scientific Program 2017

Scientific Program 2016

  • Dr. Adwaita Gore, Mumbai
  • Dr. Ajay Bapna, Jaipur
  • Dr. Ajit Venniyoor , Muscat
  • Dr. Amish Vora, Delhi
  • Dr. Amit Agarwal, Delhi
  • Dr. Amit Bhatt, Pune
  • Dr. Amit Dhiman, Ludhiana
  • Dr. Amit Ghanekar, Mumbai
  • Dr. Amit Rauthan, Bangalore
  • Dr. Amol Dongre, Nagpur
  • Dr. Anand Pathak, Nagpur
  • Dr. Anil Heroor, Mumbai
  • Dr. Anubha Bharthuar, Jalandhar
  • Dr. Anupama Mane, Pune
  • Dr. Anurag Srivastava , Delhi
  • Dr. Anusheel Munshi, Delhi
  • Dr. Arun Warrier, Cochin
  • Dr. Arvind Krishnamurthy, Chennai
  • Dr. Ashish Singh, Vellore
  • Dr. Avinash Deo , Mumbai
  • Dr. B. K. Smruti, Mumbai
  • Dr. Beela Sara Mathew, Trivandrum
  • Dr. Bharat Bhosale, Mumbai
  • Dr. Bharat Parikh, Ahmedabad
  • Dr. Bharat Vaswani, Hyderabad
  • Dr. Bharath Rangarajan, Coimbatore
  • Dr. Bhavna Parikh, Mumbai
  • Dr. Bhawana Sirohi, Delhi
  • Dr. Bhooshan Zade, Pune
  • Dr. Biswajit Dubashi, Pondicherry
  • Dr. BKC Mohan Prasad, Madurai
  • Dr. Boman Dhabhar, Mumbai
  • Dr. C. J. Tamane, Aurangabad
  • Dr. Chirag Desai, Ahmedabad
  • Dr. D C Doval, Delhi
  • Dr. D. K. Vijaykumar , Cochin
  • Dr. Devavrat Arya, Delhi
  • Dr. G. S. Bhattacharyya, Kolkata
  • Dr. G. Suryanarayana Raju, Hyderabad
  • Dr. Ganapathi Ramanan, Chennai
  • Dr. Gautam Goyal, Lucknow
  • Dr. Geeta Kadayaprath, Delhi
  • Dr. Govind Babu, Bangalore
  • Dr. Hari Goel, Mumbai
  • Dr. Harit Chaturvedi, Delhi
  • Dr. Hemant Malhotra, Jaipur
  • Dr. Indoo Ambulkar, Mumbai
  • Dr. Jyoti Bajpai, Mumbai
  • Dr. Jyoti Wadhva, Delhi
  • Dr. K. C. Lakshmaiah, Bangalore
  • Dr. K. Sambasivaiah, Hyderabad
  • Dr. Krishna Prasad, Mangalore
  • Dr. Lokesh Viswanath, Bangalore
  • Dr. Madhuchanda Kar, Kolkata
  • Dr. Maheboob Basade, Mumbai
  • Dr. Mandar Nadkarni, Mumbai
  • Dr. Manikandan Dhanushkodi, Chennai
  • Dr. Manish Singhal, Delhi
  • Dr. Manisha Singh, Patna
  • Dr. Meenu Walia , Delhi
  • Dr. Mehul Bhansali, Mumbai
  • Dr. Monica Malik, Hyderabad
  • Dr. Nagesh Sirsath, Pune
  • Dr. Narayanan Prasad, Bangalore
  • Dr. Narayanankutty Warrier, Calicut
  • Dr. Neelesh Reddy, Bangalore
  • Dr. Neha Choudhary, Kolkata
  • Dr. Nilesh Lokeshwar, Mumbai
  • Dr. Nirmal Raut, Mumbai
  • Dr. Nita Nair, Mumbai
  • Dr. Peush Bajpai, Delhi
  • Dr. Poonam Patil, Bangalore
  • Dr. Pranjali Gadgil, Pune
  • Dr. Prasenjit Chatterjee, Kolkata
  • Dr. Priya Tiwari, Delhi
  • Dr. R. Gopal, Mumbai
  • Dr. R. K. Deshpande, Mumbai
  • Dr. Radheshyam Naik, Bangalore
  • Dr. Raj Nagarkar, Nashik
  • Dr. Rajiv Sarin, Mumbai
  • Dr. Rakesh Taran, Indore
  • Dr. Ramesh Nimmagadda, Chennai
  • Dr. Ramesh Sarin, Delhi
  • Dr. Randeep Singh, Delhi
  • Dr. Ravi Wategaonkar, Pune
  • Dr. Rejiv Rajendranath, Chennai
  • Dr. Roshni Pande, Jabalpur
  • Dr. S. H. Advani, Mumbai
  • Dr. Sachin Hingmire, Pune
  • Dr. Sanjay Deshmukh, Pune
  • Dr. Seema Gulia, Mumbai
  • Dr. Senthil Rajappa, Hyderabad
  • Dr. Shailesh Bondarde, Nashik
  • Dr. Shailesh Talati , Ahmedabad
  • Dr. Shalaka Joshi, Mumbai
  • Dr. Shashank Pandya, Ahmedabad
  • Dr. Shirish Alurkar, Ahmedabad
  • Dr. Shishir Shetty, Mumbai
  • Dr. Sidharth Sahni, Delhi
  • Dr. Suchanda Goswami, Kolkata
  • Dr. T. P. Sahoo, Bhopal
  • Dr. T. Raja, Chennai
  • Dr. Tabassum Wadasadawala, Mumbai
  • Dr. Tanveer Maksud, Surat
  • Dr. Tanweer Shahid, Kolkata
  • Dr. Tejinder Singh, Mumbai
  • Dr. Tushar Patil, Pune
  • Dr. V. Kannan, Mumbai
  • Dr. Vamshi Krishna, Hyderabad
  • Dr. Vashishth Maniar, Mumbai
  • Dr. Vedant Kabra, Delhi
  • Dr. Vineet Gupta, Delhi
  • Dr. Vinod Raina, Delhi
  • Dr. Vivek Agarwala , Kolkata
Dr. Hope Rugo, USA

Clinical Professor, Department of Medicine (Hematology/Oncology);
and Director, Breast Oncology Clinical Trials Program, UCSF
San Francisco, CA

Dr. Hope Rugo is a medical oncologist and hematologist specializing in breast cancer research and treatment. A Clinical Professor of Medicine, Dr. Rugo joined the Breast Care Center in 1999 after a decade of experience at UCSF in malignant hematology and bone marrow transplantation for a variety of diseases, including breast cancer. She entered the field of breast cancer in order to incorporate novel therapies based on an understanding of the biology of cancer with excellent quality of care into the treatment of women with breast cancer.

Dr. Rugo is the Director of the Breast Oncology Clinical Trials Program, and is the principalinvestigator of multiple clinical trials focusing on combining novel targeted therapeutics with standard treatment to improve the treatment of both early and late stage breast cancer. In addition, Dr. Rugo is working on studies to evaluate cognitive function in women receiving chemotherapy for breast cancer, as well as novel ways to reduce toxicity from therapy. Dr. Rugo has established collaborations with a number of other large academic medical centers for the purpose of expanding the novel therapies that are available for our patients, including herbal agents that appear to have an antitumor effect in the laboratory. She is an active member of the national cooperative group, CALGB, and she is a founding member of the Breast Cancer Research Consortium, as well as serving as an investigator in the UCSF Breast SPORE (the Bay Area Specialized Program of Research Excellence in Breast Cancer). Dr. Rugo teaches medical students, physicians and regularly lectures locally, nationally and internationally on subjects relating to the treatment of breast cancer. At UCSF, Dr. Rugo runs the Breast Forum, an open bimonthly evening educational session for breast cancer patients, families and friends from throughout the bay area.

Dr. Rugo graduated from the University of Pennsylvania School of Medicine in 1983. She completed a residency in internal medicine and primary care followed by a fellowship in hematology and oncology at the University of California San Francisco. She was a post-doctoral fellow in immunology participating in laboratory research at Stanford University from 1988-1990. In 1990, Dr. Rugo joined the faculty at UCSF in the Division of Hematology and Oncology. Dr. Rugo has been recognized for her excellence in both patient care and in teaching of both medical students and training physicians. She has received several awards including the Bank of America Gianini Foundation Award and a UCSF Clinical Cancer Center Investigator Research Program intra-mural award. In 2006, she was honored for her work in Breast Cancer Research by the Friends of the Breast Care Center.

Dr. Shaheenah Dawood, Dubai

M. B. B.Ch

Dr. Shaheenah Dawood is the Head of Medical Oncology and the Head of the Breast Cancer Program at Dubai Hospital in the United Arab Emirates. Dr. Dawood completed her M.B.B.Ch at Dubai Medical College in 1998 and a Master of Public Health degree at the Harvard School of Public Health, Boston, USA in 2008. Her postgraduate medical training programs include a Fellowship at McGill University in Canada in 2006, and the Susan Komen Breast Cancer Fellowship at the University of Texas M.D. Anderson Cancer Center in 2007.

Dr. Dawood is a member of various professional organizations, including the American Society of Clinical Oncology (ASCO), the American Association of Cancer Research (AACR), the Canadian Association of Medical Oncologists, the Emirates Medical Association, and the Inflammatory Breast Cancer Research Group. She is also the co-director of the Middle East Research Network.

Dr. Dawood has been a primary author or collaborator on over 50 peer-reviewed publications in national and international journals. In addition, she has collaborated with other authors to write a number of book chapters. Dr. Dawood has also been involved as a journal reviewer and as an editorial consultant for many cancer-related journals.

Research Interests: Dr. Dawood’s researcher interests encompass Triple Negative Breast Cancer, Inflammatory Breast Cancer, Metastases, as well as life-style issues and survival outcome of cancer patients.

We will get back soon......!